drugset / Trial / NCT02713490

Local Infiltration Analgesia With and Without EXPAREL Following Total Knee Arthroplasty

NCT02713490 ↗

Phase 4 Completed 140 enrolled Pacira Pharmaceuticals, Inc
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a Phase 4, multicenter, randomized, double-blind, controlled trial in approximately 140 adult subjects undergoing primary unilateral TKA under spinal anesthesia with bupivacaine HCl (10-15 mg).

Timeline

Start
2016-04-18
Primary completion
2017-02-08
Completion
2017-02-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 0.5 % Other
Comparator Bupivacaine Other / unclassified 266 mg Other

Indications

No indication recorded.